|
Originally published In Press as doi:10.1074/jbc.R100042200 on August 29, 2001
J. Biol. Chem., Vol. 276, Issue 43, 39501-39504, October 26, 2001
MINIREVIEW
The Biology and Enzymology of Protein
N-Myristoylation*,
Thalia A.
Farazi §,
Gabriel
Waksman¶, and
Jeffrey I.
Gordon
From the Departments of Molecular Biology and
Pharmacology and ¶ Biochemistry and Molecular Biophysics,
Washington University School of Medicine,
St. Louis, Missouri 63110
 |
INTRODUCTION |
Protein N-myristoylation refers to
the covalent attachment of myristate, a 14-carbon saturated fatty acid,
to the N-terminal glycine of eukaryotic and viral proteins.
N-Myristoylproteins have diverse functions and intracellular
destinations. They include proteins involved in a wide variety of
signal transduction cascades. In general, N-myristoylation
is an irreversible protein modification that occurs co-translationally
following removal of the initiator methionine residue by cellular
methionylaminopeptidases (1, 2). N-Myristoylation can also
occur post-translationally, as in the case of the pro-apoptotic protein
BID where proteolytic cleavage by caspase 8 reveals a "hidden"
myristoylation motif (3).
N-Myristoylation promotes weak and reversible
protein-membrane and protein-protein interactions (4, 5). Typically,
myristate acts in concert with other mechanisms to regulate protein
targeting and function. Some proteins (e.g. MARCKS, Src)
employ "myristoyl-electrostatic switches" where membrane
association is promoted by myristate plus electrostatic interactions
between positively charged protein side chains and negatively charged
membrane phospholipids (6, 7). In other N-myristoylproteins,
ligand binding (Arfs, recoverin (8, 9)) or proteolytic cleavage (HIV-1
Pr55gag/p17MA (10)) produces a conformational change that
exposes or sequesters the acyl chain ("myristoyl-conformational
switch").
A subset of proteins undergoes post-translational covalent modification
with one or more palmitoyl groups after N-myristoylation. Examples of these dually acylated proteins include members of the Src
family of tyrosine kinases (Fyn, Lck), subunits of heterotrimeric G-proteins, endothelial nitric-oxide synthase, and the yeast vacuolar protein Vac8p (11). Cys serves as the acceptor site for palmitate. S-Palmitoylation is reversible, providing a mechanism for
regulated interactions between these N-myristoylproteins and
cellular membranes and/or other proteins (7, 12). For example, turnover
of the palmitoyl moiety in N-myristoylated Gi
subunits is stimulated by activation of the 5-hydroxytryptamine-1a
receptor (13). Depalmitoylation of Gi has no overt
effects on membrane association (14) but may have functional
consequences for G-protein de-activation; in vitro studies
have shown that S-acylated Gi is resistant to the GTPase-activating protein activity of RGS
(regulators of G-protein signaling)
proteins (15).
The "kinetic bilayer trapping" hypothesis (16) was proposed to
explain the operation of this "dual fatty acylation switch." According to the hypothesis, proteins with myristate are able to
transiently interact with membranes. This allows subsequent palmitoylation by plasma membrane-associated palmitoyl
S-transferase (17) and stable membrane association because
of a slower off rate of the dually acylated product. Dual acylation
also influences compartmentalization to specialized plasmalemmal
microdomains (18). In lymphocytes, dual acylation of non-receptor
tyrosine kinases (Fyn, Lck) is necessary for their targeting to lipid
rafts. Inhibiting S-acylation by Cys to Ser mutation, or
2-bromopalmitate treatment, delocalizes these kinases from rafts and is
associated with loss of signaling through the T-cell receptor (19, 20). Mutagenesis studies indicate that both N-myristoylation and
S-palmitoylation are needed to target endothelial
nitric-oxide synthase to caveolae (21).
 |
Myristoyl-CoA:Protein N-Myristoyltransferase Is an Essential
Enzyme |
N-Myristoylation is catalyzed by myristoyl-CoA:protein
N-myristoyltransferase
(Nmt),1 a member of the GNAT
superfamily of proteins (22). Nineteen Nmts have been identified from
15 species (see supplemental material for alignments plus a
phylogenetic analysis). Genetic studies have established the essential
requirement for Nmt in a number of these species. The
Saccharomyces cerevisiae genome contains a single
NMT gene. A nmt1 null allele causes recessive
lethality (23). Arabidopsis thaliana contains two
NMT genes. Forced expression of Nmt1 cRNA produces stunted
growth and reduced survival of transgenic plants (24). A null mutation
of Drosophila melanogaster dNMT results in embryonic
lethality (25). Mutant embryos display a range of phenotypes, including
morphogenetic abnormalities associated with disordered cell movement
and widespread apoptosis. Some of these changes phenocopy changes
produced by genetic manipulations affecting D. melanogaster
N-myristoylproteins involved in dynamic rearrangements of
the actin cytoskeleton, e.g. non-receptor tyrosine kinases
(Dsrc42A, Dsrc64B). Finally, a NMT null allele causes lethality in the two principal causes of systemic fungal infections in
immunocompromised humans, Candida albicans and
Cryptococcus neoformans (26, 27).
Three mammalian species (human, mouse, Bos taurus) each
possess two Nmts (termed type I and type II (28)). Type I Nmts show a
high degree of conservation across species, as do the orthologous type
II Nmts. Type I and II Nmts are most divergent at their N termini (see
alignment in the supplemental material). Glover et al. (29)
reported that the extended N-terminal domain of type I human Nmt may be
involved in targeting the enzyme to the ribosome but is not required
for activity in vitro. The divergent N-terminal domains of
the two Nmt isoforms may allow differential cellular localization,
thereby effecting co-translational ribosome-based or
post-translational cytosol-based protein acylation.
 |
Nmt Is a Therapeutic Target |
Nmt represents an attractive therapeutic target given its
requirement for the survival of several human pathogens. Different classes of Nmt inhibitors have been identified including analogs of
myristate and myristoyl-CoA (30-36), myristoylpeptide derivatives (2,
37), and histidine analogs (38). All studied Nmts exhibit a preference
for myristoyl-CoA. However, they have divergent peptide substrate
specificities. Therefore, peptide derivatives offer an opportunity to
generate species-selective inhibitors. A large library of
peptidomimetics has been developed through depeptidization of an
octapeptide representing the N-terminal sequence of a known yeast Nmt
substrate, Arf2p (GLYASKLS, i.e. Ref. 39). Some
members of this compound library have fungistatic or fungicidal
activity against C. albicans and C. neoformans
(40-42).
 |
Kinetic Studies of S. cerevisiae Nmt1p |
S. cerevisiae Nmt (Nmt1p) is the best studied of the
known Nmts. It is a monomer with no known co-factor requirements or
post-translational modifications. Nmt1p is highly selective for
myristoyl-CoA in vitro and in vivo. In vitro
kinetic studies of synthetic peptides derived from the N-terminal
sequences of known N-myristoylproteins have produced a set
of empiric rules for identifying candidate substrates. The following
criteria, based on these empiric rules, were used to search the
S. cerevisiae genome data base for known or
putative Nmt substrates: (a) Gly absolutely required at the +1 position; (b) charged residues, aromatics and Pro not
allowed at +2; (c) all amino acids allowed at +3 and +4;
(d) Ser, Thr, Ala, Gly, Cys, or Asn permitted at +5; and
(e) all but Pro allowed at +6. Seventy-one ORFs (1% of the
total) were identified. Among these proteins, there was a marked
preference for Ser at position +5 (37/71) and for Lys at +6
(16/71).
Steady state kinetic, isothermal titration calorimetric, and x-ray
crystallographic studies (43-45) all support the conclusion that Nmt1p
follows an Ordered Bi Bi reaction mechanism. The apo-enzyme binds
myristoyl-CoA to form a Nmt1p·myristoyl-CoA binary complex that is
competent to acquire peptide substrates. Conversion of the
enzyme·substrate complex to the enzyme·product complex (chemical transformation) is followed by release of CoA and then
myristoylpeptide. Pre-steady state kinetic analyses indicate that the
rate-determining step occurs after the chemical transformation,
i.e. the rate of chemical transformation is 50-200-fold
faster than the overall rate, depending upon the peptide substrate
(46). Measuring enzymatic rates in the presence of increasing buffer
microviscosity (47), as well as structural studies of Nmt1p complexed
with substrates and substrate analogs (45), suggest that this step
corresponds to a conformational change that allows product release (see below).
 |
Reaction Mechanism of Nmt |
Structural studies of Nmt have provided insights about how it
catalyzes N-myristoylation through a direct nucleophilic
addition-elimination reaction. The x-ray structure of C. albicans apo-Nmt has been determined to 2.45-Å resolution (48),
as have the structures of an S. cerevisiae
Nmt1p·myristoyl-CoA binary complex (2.2 Å (45)) and two ternary
complexes: Nmt1p·S-(2-oxo)pentadecyl-CoA·SC-58272 (2.9 Å (49)) and Nmt1p·S-(2-oxo)pentadecyl-CoA·GLYASKLA (2.5 Å (45)). S-(2-oxo)pentadecyl-CoA is a non-hydrolyzable
myristoyl-CoA analog with a methylene group interposed between the
reactive thioester carbonyl and sulfur (30). It is a potent competitive inhibitor of S. cerevisiae Nmt1p (Ki = 5 nM) that binds to the apo-enzyme with a similar
thermodynamic signature as myristoyl-CoA (44). SC-58272 is a potent
competitive peptidomimetic inhibitor (Ki = 43 nM) derived from the Arf2p-related octapeptide substrate GLYASKLA. SC58272 retains two elements critical for recognition (Ser, Lys) but replaces the N-terminal GLYA with a 2-methylimidazole plus a rigidified carbon linker
(p-(2-methylimidazole-N-butyl)phenylacetyl) and
the C-terminal LA with cyclohexylethyl (39).
The Nmt1p fold consists of a saddle-shaped -sheet flanked by helices. There is pseudo-2-fold symmetry. The N-terminal half forms the
myristoyl-CoA binding site. The C-terminal half forms the bulk of the
peptide binding site (Fig.
1A). Each half has a fold
similar to the core structure of GNAT superfamily members (22).
Residues 1-54 in C. albicans apo-Nmt and 1-33 in the
binary and ternary Nmt1p complexes are disordered.

View larger version (42K):
[in this window]
[in a new window]
|
Fig. 1.
Stereo ribbon diagrams of the structure of
Nmt1p showing conformational changes induced by substrate binding.
A, ternary complex of S. cerevisiae
Nmt1p·S-(2-oxo)pentadecyl-CoA·GLYASKLA, with
myristoyl-CoA modeled in place of S-(2-oxo)pentadecyl-CoA.
Secondary structure code: helices, aqua; 310
helices, purple; strands, green; loops,
brown. Atom color code: oxygen, red; phosphorus,
pink; carbon, silver; nitrogen,
purple; sulfur, yellow. Adapted from Ref. 45.
B and C, comparison of the S. cerevisiae binary Nmt1p·myristoyl-CoA complex
(yellow) with C. albicans apo-Nmt
(magenta). Two major conformational changes occur with
myristoyl-CoA binding: ordering of residues 34-55 with formation of a
310 helix (A') (panel B); movement of the Ab
loop to open the "lid" to the peptide binding site (panel
C). D, comparison of the S. cerevisiae
binary complex (yellow) with the S. cerevisiae
ternary complex (green). The "lid" (Ab loop) closes upon
binding of peptide.
|
|
Myristoyl-CoA Binding--
Binding of myristoyl-CoA to apo-Nmt1p
induces two conformational changes: (a) formation of a
310 helix (A') from part of the disordered N terminus to
complete the myristoyl-CoA binding site (Fig. 1B) and
(b) a change in the loop connecting helix A and strand b to
open a "lid" overlying the peptide binding site (see Ab loop in
Fig. 1C). The pantetheine of CoA forms an important part of
this peptide binding site (Fig.
2C).

View larger version (64K):
[in this window]
[in a new window]
|
Fig. 2.
Stereo ribbon diagrams showing details of
substrate binding to Nmt1p. A, myristoyl-CoA binding
site. B-D, peptide binding site occupied by GLYASKLA. Note
that in panel D the Gly-1 amine has been rotated 180°
around in accord with the proposed mechanism for its nucleophilic
attack on the thioester carbonyl. Adapted from Ref. 45.
|
|
Bound myristoyl-CoA has a conformation resembling a question mark (Fig.
2A). As described below, this conformation may facilitate product release. The thioester carbonyl of myristoyl-CoA is H-bonded to
the backbone amides of Phe-170 and Leu-171 (Fig. 2A). These two residues, positioned in a bulge in strand e, form an oxyanion hole that polarizes the carbonyl. (Oxyanion holes are present at
analogous positions in other GNATs; see Protein Data Bank accession numbers 1CJW, 1QSN, 1BO4 and Ref. 22.)
Nmtlp uses the elements that produce bends at C-1 and C-6 of myristate,
as well as the floor of its acyl-CoA binding pocket, as key landmarks
to measure and properly position myristoyl-CoA. The binding site
structure indicates that the two additional methylenes of palmitoyl-CoA
could not be accommodated without affecting positioning of its C-1
carbonyl in the oxyanion hole.
Kinetic studies of stopped flow tryptophan fluorescence reveal that
myristoyl-CoA binding occurs as a two-step process (46). The fast phase
is most likely diffusion-controlled. The slow phase is independent of
myristoyl-CoA concentration and most likely represents the rate of
formation of the N-terminal 310 A' helix.
Peptide Binding--
Nmt can be distinguished from other GNAT
family members by the remarkable diversity of its peptide substrates.
The only reported structural information about interactions between a
Nmt and its peptide substrates comes from the ternary structure with
bound Arf2p-derived GLYASKLA. Gly-1 is positioned 6.3 Å from
the thioester carbonyl of myristoyl-CoA in the 2.5-Å resolution
structure, a distance that can be shortened by 2 Å after rotation
around (see Fig. 2, C and D, plus the
discussion of catalytic mechanism below). The environment around Gly-1
provides several H-bond interactions; the Gly-1 nitrogen is 2.9 Å from
the OT1 atom of Leu-455, 3.9 Å from the O hydroxyl of Thr-205, and
4.2 Å from the O atom of Asn-169 (Fig. 2, B and
C).
Contacts between the side chain of Leu-2 of the peptide and pantetheine
of myristoyl-CoA complete formation of the peptide binding site and at
the same time generate a 90o bend in the peptide backbone,
turning it away from myristoyl-CoA and toward a peptide binding groove
(Fig. 2B). Leu is accommodated in a hydrophobic pocket.
Replacing Leu with Ala in GLYASKLA results in a ~10-fold reduction in
the chemical transformation rate, suggesting that this residue is
important in positioning the reactive Gly-1 amine (47).
Tyr-3 is accommodated in an aromatic cluster composed of tyrosines from
the active site of Nmt whereas Ala-4 lies in a large hydrophobic pocket
that could accommodate uncharged residues (Fig. 2B). Ser-5,
which is greatly preferred in yeast N-myristoylproteins, is
H-bonded to the side chain of His-221, as well as the backbone amides
of Asp-417 and Gly-418 (Fig. 2B). Lys-6, also preferred in
yeast N-myristoylproteins, is H-bonded to the side chain of Asp-417, whereas its aliphatic portion is coordinated by the phenyl rings of Phe-111 and Phe-234 and the aliphatic component of Arg-107 (Fig. 2B).
The structural basis for observed differences in the peptide substrate
specificities of orthologous yeast/fungal and human Nmts remains to be
defined. The residues described above in S. cerevisiae Nmt1p
that interact with GLYASKLA are highly conserved. However, Phe-334 and
Ile-347, which form part of a hydrophobic pocket involved in
coordination of Ala-4 in GLYASKLA, are represented by Ser and Ala,
respectively, in the two human Nmts. This suggests that human Nmt could
accommodate bulkier and/or more polar residues at position +4 of its substrates.
Kinetic studies of stopped flow tryptophan fluorescence have shown that
binding of peptide substrate to the binary Nmt1p·acyl-CoA complex is
a single-step process that is most likely diffusion-controlled (46).
Binding leads to a change in the conformation of the Ab loop that
serves to close the "lid" on the peptide binding site (Arg-107,
Phe-111 interact with the aliphatic portion of Lys-6 (Figs.
1D and 2B)). In the ternary complex of Nmt1p
containing SC58272, the Ab loop forms additional contacts with the
dipeptide inhibitor. This suggests that the extent of ordering of the
Ab loop may correlate with the overall catalytic efficiency of
different Nmt1p substrates. SC58272 presumably functions as a potent
inhibitor, at least in part, because it is able to form a tight,
dead-end complex with extensive contacts with the Ab loop. These
observations have implications for designing future species-selective
inhibitors (see below).
Chemical Transformation--
Structural studies, combined with
pre-steady state and steady state kinetic analyses of site-directed
Nmt1p mutants (47) have identified several elements in the active site
of the enzyme that facilitate the myristoyl transfer reaction. The
proposed reaction is illustrated by a movie available in the
supplemental material. The oxyanion hole, formed by the backbone amides
of Phe-170 and Leu-171, polarizes the reactive carbonyl of bound myristoyl-CoA prior to subsequent nucleophilic attack by the N-terminal Gly-1 of a peptide substrate. The C-terminal carboxylate of Leu-455, positioned within 2.9 Å from the N-terminal Gly nitrogen of the acceptor peptide, functions as the catalytic base that deprotonates the
Gly ammonium to a nucleophilic amine. Removal of the C-terminal Met-454, Leu-455 of Nmt1p results in a 300-400-fold reduction in the
chemical transformation rate and converts the rate-limiting step of the
enzyme from a step after chemical transformation to the transformation
itself (47). In other GNAT members, a side chain carboxylate functions
as a catalytic base to facilitate nucleophilic attack of a primary
amino group on the thioester carbonyl of acetyl-CoA (50), although this
role is assumed by the backbone carbonyl of Asn-134 in S. cerevisiae glucosamine-6-phosphate N-acetyltransferase
1 (51).
A 180-Å rotation of the Gly-1 amine along reduces the distance
between it and the thioester carbonyl of myristoyl-CoA from 6.3 to 4.3 Å (Fig. 2, C and D). H-bonding interactions
between the Gly-1 amine, Asn-169, and Thr-205 position the amine along the reaction trajectory and facilitate nucleophilic attack. The oxyanion hole together with the H-bonding network formed by Asn-169 and
Thr-205 stabilize the developing tetrahedral intermediate. Subsequent
collapse of the tetrahedral intermediate leads to extrusion of CoA.
During this process, the Gly1 amine is deprotonated, whereas the
thiolate leaving group of CoA is re-protonated, presumably through
proton exchange between these two groups (see the movie in supplemental
material). The thiolate leaving group is stabilized by the N-6 amine of
the CoA adenine. This intramolecular stabilization mechanism is
economical and accounts for the bent conformation of CoA; a globular
compact CoA should facilitate diffusion from the active site.
Steady state kinetics studies, performed with increasing amounts of
microviscogen, combined with the x-ray crystallographic studies of the
binary and ternary Nmt complexes suggest that the rate-limiting step in
the reaction is an isomerization step. The isomerization could involve
reversal of the changes that occur upon myristoyl-CoA binding,
i.e. disordering of the N-terminal 310 A' helix
and altering the conformation of the Ab loop.
 |
Prospectus |
Defining the details of the rate-limiting step of Nmt will require
additional kinetic as well as structural (e.g. NMR) studies. The information gleaned may provide new leads for designing Nmt inhibitors useful for manipulating protein N-myristoylation
in various cell types, model organisms, and/or pathogens. Bi-substrate analogs that exploit the shared preference of orthologous Nmts for
myristoyl-CoA and their divergent peptide substrate
specificities may yield useful species-selective agents. Selectivity
and potency may be enhanced by incorporating features that affect the
conformation and dynamics of the Ab loop of the enzyme.
A key but unresolved question is how Nmt acquires its substrates within
cells and whether this process involves additional protein partners.
The discovery of two Nmt isoforms with divergent N termini raises the
possibility that this domain may affect enzyme activity by regulating
recognition or interactions with substrates or the intracellular
location of Nmt.
 |
ACKNOWLEDGEMENTS |
We thank George Gokel and Maurine Linder for
very helpful comments and Herb Chiang for producing the movie of the
proposed mechanism of Nmt.
 |
FOOTNOTES |
*
This minireview will be reprinted
in the 2001 Minireview Compendium, which
will be available in December, 2001. Work cited from our laboratory was funded by National
Institutes of Health Grant AI38200.
The on-line version of this article (available at
http://www.jbc.org) contains a comparison of orthologous
Nmts and a movie of the proposed catalytic mechanism.
§
Supported in part by Medical Scientist Training Grant GM07200.
To whom correspondence should be addressed. E-mail:
jgordon@molecool.wustl.edu.
Published, JBC Papers in Press, August 29, 2001, DOI 10.1074/jbc.R100042200
 |
ABBREVIATIONS |
The abbreviation used is:
Nmt, N-myristoyltransferase.
 |
REFERENCES |
| 1.
|
Wolven, A.,
Okamura, H.,
Rosenblatt, Y.,
and Resh, M. D.
(1997)
Mol. Biol. Cell
8,
1159-1173[Abstract]
|
| 2.
|
Towler, D. A.,
Adams, S. P.,
Eubanks, S. R.,
Towery, D. S.,
Jackson-Machelski, E.,
Glaser, L.,
and Gordon, J. I.
(1987)
Proc. Natl. Acad. Sci. U. S. A.
84,
2708-2712[Abstract/Free Full Text]
|
| 3.
|
Zha, J.,
Weiler, S.,
Oh, K. J.,
Wei, M. C.,
and Korsmeyer, S. J.
(2000)
Science
290,
1761-1765[Abstract/Free Full Text]
|
| 4.
|
Peitzsch, R. M.,
and McLaughlin, S.
(1993)
Biochemistry
32,
10436-10443[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Murray, D.,
Ben-Tal, N.,
Honig, B.,
and McLaughlin, S.
(1997)
Structure
5,
985-989[Medline]
[Order article via Infotrieve]
|
| 6.
|
McLaughlin, S.,
and Aderem, A.
(1995)
Trends Biochem. Sci.
20,
272-276[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
Resh, M. D.
(1999)
Biochim. Biophys. Acta
1451,
1-16[Medline]
[Order article via Infotrieve]
|
| 8.
|
Goldberg, J.
(1998)
Cell
95,
237-248[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Ames, J. B.,
Ishima, R.,
Tanaka, T.,
Gordon, J. I.,
Stryer, L.,
and Ikura, M.
(1997)
Nature
389,
198-202[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Hermida-Matsumoto, L.,
and Resh, M. D.
(1999)
J. Virol.
73,
1902-1908[Abstract/Free Full Text]
|
| 11.
|
Dunphy, J. T.,
and Linder, M. E.
(1998)
Biochim. Biophys. Acta
1436,
245-261[Medline]
[Order article via Infotrieve]
|
| 12.
|
Linder, M. E.
(2000)
in
The Enzymes: Protein Lipidation
(Tamanoi, F.
, and Sigman, D. S., eds), Vol. XXI
, pp. 215-240, Academic Press, Inc., San Diego, CA
|
| 13.
|
Chen, C. A.,
and Manning, D. R.
(2000)
J. Biol. Chem.
275,
23516-23522[Abstract/Free Full Text]
|
| 14.
|
Huang, C.,
Duncan, J. A.,
Gilman, A. G.,
and Mumby, S. M.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
412-417[Abstract/Free Full Text]
|
| 15.
|
Tu, Y.,
Wang, J.,
and Ross, E. M.
(1997)
Science
278,
1132-1135[Abstract/Free Full Text]
|
| 16.
|
Shahinian, S.,
and Silvius, J. R.
(1995)
Biochemistry
34,
3813-3822[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Dunphy, J. T.,
Greentree, W. K.,
Manahan, C. L.,
and Linder, M. E.
(1996)
J. Biol. Chem.
271,
7154-7159[Abstract/Free Full Text]
|
| 18.
|
Oh, P.,
and Schnitzer, J. E.
(2001)
Mol. Biol. Cell
12,
685-698[Abstract/Free Full Text]
|
| 19.
|
Kabouridis, P. S.,
Magee, A. I.,
and Ley, S. C.
(1997)
EMBO J.
16,
4983-4998[CrossRef][Medline]
[Order article via Infotrieve]
|
| 20.
|
Webb, Y.,
Hermida-Matsumoto, L.,
and Resh, M. D.
(2000)
J. Biol. Chem.
275,
261-270[Abstract/Free Full Text]
|
| 21.
|
Shaul, P. W.,
Smart, E. J.,
Robinson, L. J.,
German, Z.,
Yuhanna, I. S.,
Ying, Y.,
Anderson, R. G.,
and Michel, T.
(1996)
J. Biol. Chem.
271,
6518-6522[Abstract/Free Full Text]
|
| 22.
|
Dyda, F.,
Klein, D. C.,
and Hickman, A. B.
(2000)
Annu. Rev. Biophys. Biomol. Struct.
29,
81-103[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
Duronio, R. J.,
Towler, D. A.,
Heuckeroth, R. O.,
and Gordon, J. I.
(1989)
Science
243,
796-800[Abstract/Free Full Text]
|
| 24.
|
Qi, Q.,
Rajala, R. V.,
Anderson, W.,
Jiang, C.,
Rozwadowski, K.,
Selvaraj, G.,
Sharma, R.,
and Datla, R.
(2000)
J. Biol. Chem.
275,
9673-9683[Abstract/Free Full Text]
|
| 25.
|
Ntwasa, M.,
Aapies, S.,
Schiffmann, D. A.,
and Gay, N. J.
(2001)
Exp. Cell Res.
262,
134-144[CrossRef][Medline]
[Order article via Infotrieve]
|
| 26.
|
Weinberg, R. A.,
McWherter, C. A.,
Freeman, S. K.,
Wood, D. C.,
Gordon, J. I.,
and Lee, S. C.
(1995)
Mol. Microbiol.
16,
241-250[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
Lodge, J. K.,
Jackson-Machelski, E.,
Toffaletti, D. L.,
Perfect, J. R.,
and Gordon, J. I.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
12008-12012[Abstract/Free Full Text]
|
| 28.
|
Giang, D. K.,
and Cravatt, B. F.
(1998)
J. Biol. Chem.
273,
6595-6598[Abstract/Free Full Text]
|
| 29.
|
Glover, C. J.,
Hartman, K. D.,
and Felsted, R. L.
(1997)
J. Biol. Chem.
272,
28680-28689[Abstract/Free Full Text]
|
| 30.
|
Paige, L. A.,
Zheng, G. Q.,
DeFrees, S. A.,
Cassady, J. M.,
and Geahlen, R. L.
(1989)
J. Med. Chem.
32,
1665-1667[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Paige, L. A.,
Zheng, G. Q.,
DeFrees, S. A.,
Cassady, J. M.,
and Geahlen, R. L.
(1990)
Biochemistry
29,
10566-10573[CrossRef][Medline]
[Order article via Infotrieve]
|
| 32.
|
Devadas, B.,
Lu, T.,
Katoh, A.,
Kishore, N. S.,
Wade, A. C.,
Mehta, P. P.,
Rudnick, D. A.,
Bryant, M. L.,
Adams, S. P.,
Li, Q.,
Gokel, G. W.,
and Gordon, J. I.
(1992)
J. Biol. Chem.
267,
7224-7239[Abstract/Free Full Text]
|
| 33.
|
Cordo, S. M.,
Candurra, N. A.,
and Damonte, E. B.
(1999)
Microbes Infect.
1,
609-614[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Harper, D. R.,
Gilbert, R. L.,
Blunt, C.,
and McIlhinney, R. A.
(1993)
J. Gen. Virol.
74,
1181-1184[Abstract/Free Full Text]
|
| 35.
|
Saermark, T.,
Kleinschmidt, A.,
Wulff, A. M.,
Andreassen, H.,
Magee, A.,
and Erfle, V.
(1991)
AIDS
5,
951-958[Medline]
[Order article via Infotrieve]
|
| 36.
|
Nadler, M. J.,
Harrison, M. L.,
Ashendel, C. L.,
Cassady, J. M.,
and Geahlen, R. L.
(1993)
Biochemistry
32,
9250-9255[CrossRef][Medline]
[Order article via Infotrieve]
|
| 37.
|
Furuishi, K.,
Matsuoka, H.,
Takama, M.,
Takahashi, I.,
Misumi, S.,
and Shoji, S.
(1997)
Biochem. Biophys. Res. Commun.
237,
504-511[CrossRef][Medline]
[Order article via Infotrieve]
|
| 38.
|
Raju, R. V.,
Datla, R. S.,
Warrington, R. C.,
and Sharma, R. K.
(1998)
Biochemistry
37,
14928-14936[CrossRef][Medline]
[Order article via Infotrieve]
|
| 39.
|
Devadas, B.,
Zupec, M. E.,
Freeman, S. K.,
Brown, D. L.,
Nagarajan, S.,
Sikorski, J. A.,
McWherter, C. A.,
Getman, D. P.,
and Gordon, J. I.
(1995)
J. Med. Chem.
38,
1837-1840[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
Lodge, J. K.,
Jackson-Machelski, E.,
Devadas, B.,
Zupec, M. E.,
Getman, D. P.,
Kishore, N.,
Freeman, S. K.,
McWherter, C. A.,
Sikorski, J. A.,
and Gordon, J. I.
(1997)
Microbiology
143,
357-366[Abstract/Free Full Text]
|
| 41.
|
Lodge, J. K.,
Jackson-Machelski, E.,
Higgins, M.,
McWherter, C. A.,
Sikorski, J. A.,
Devadas, B.,
and Gordon, J. I.
(1998)
J. Biol. Chem.
273,
12482-12491[Abstract/Free Full Text]
|
| 42.
|
Devadas, B.,
Freeman, S. K.,
McWherter, C. A.,
Kishore, N. S.,
Lodge, J. K.,
Jackson-Machelski, E.,
Gordon, J. I.,
and Sikorski, J. A.
(1998)
J. Med. Chem.
41,
996-1000[CrossRef][Medline]
[Order article via Infotrieve]
|
| 43.
|
Rudnick, D. A.,
McWherter, C. A.,
Rocque, W. J.,
Lennon, P. J.,
Getman, D. P.,
and Gordon, J. I.
(1991)
J. Biol. Chem.
266,
9732-9739[Abstract/Free Full Text]
|
| 44.
|
Bhatnagar, R. S.,
Schall, O. F.,
Jackson-Machelski, E.,
Sikorski, J. A.,
Devadas, B.,
Gokel, G. W.,
and Gordon, J. I.
(1997)
Biochemistry
36,
6700-6708[CrossRef][Medline]
[Order article via Infotrieve]
|
| 45.
|
Farazi, T. A.,
Waksman, G.,
and Gordon, J. I.
(2001)
Biochemistry
40,
6335-6343[CrossRef][Medline]
[Order article via Infotrieve]
|
| 46.
|
Farazi, T. A.,
Manchester, J. K.,
and Gordon, J. I.
(2000)
Biochemistry
39,
15807-15816[CrossRef][Medline]
[Order article via Infotrieve]
|
| 47.
|
Farazi, T. A.,
Manchester, J. K.,
Waksman, G.,
and Gordon, J. I.
(2001)
Biochemistry
40,
9177-9186[CrossRef][Medline]
[Order article via Infotrieve]
|
| 48.
|
Weston, S. A.,
Camble, R.,
Colls, J.,
Rosenbrock, G.,
Taylor, I.,
Egerton, M.,
Tucker, A. D.,
Tunnicliffe, A.,
Mistry, A.,
Mancia, F.,
de la Fortelle, E.,
Irwin, J.,
Bricogne, G.,
and Pauptit, R. A.
(1998)
Nat. Struct. Biol.
5,
213-221[CrossRef][Medline]
[Order article via Infotrieve]
|
| 49.
|
Bhatnagar, R. S.,
Futterer, K.,
Farazi, T. A.,
Korolev, S.,
Murray, C. L.,
Jackson-Machelski, E.,
Gokel, G. W.,
Gordon, J. I.,
and Waksman, G.
(1998)
Nat. Struct. Biol.
5,
1091-1097[CrossRef][Medline]
[Order article via Infotrieve]
|
| 50.
|
Yan, Y.,
Barlev, N. A.,
Haley, R. H.,
Berger, S. L.,
and Marmorstein, R.
(2000)
Mol. Cell
6,
1195-1205[CrossRef][Medline]
[Order article via Infotrieve]
|
| 51.
|
Peneff, C.,
Mengin-Lecreulx, D.,
and Bourne, Y.
(2001)
J. Biol. Chem.
276,
16328-16334[Abstract/Free Full Text]
|
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
B. T. Emmer, C. Souther, K. M. Toriello, C. L. Olson, C. L. Epting, and D. M. Engman
Identification of a palmitoyl acyltransferase required for protein sorting to the flagellar membrane
J. Cell Sci.,
March 15, 2009;
122(6):
867 - 874.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Buglino and M. D. Resh
Hhat Is a Palmitoylacyltransferase with Specificity for N-Palmitoylation of Sonic Hedgehog
J. Biol. Chem.,
August 8, 2008;
283(32):
22076 - 22088.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. D. O. Martin, G. L. Vilas, J. A. Prescher, G. Rajaiah, J. R. Falck, C. R. Bertozzi, and L. G. Berthiaume
Rapid detection, discovery, and identification of post-translationally myristoylated proteins during apoptosis using a bio-orthogonal azidomyristate analog
FASEB J,
March 1, 2008;
22(3):
797 - 806.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Koutelou, S. Sato, C. Tomomori-Sato, L. Florens, S. K. Swanson, M. P. Washburn, M. Kokkinaki, R. C. Conaway, J. W. Conaway, and N. K. Moschonas
Neuralized-like 1 (Neurl1) Targeted to the Plasma Membrane by N-Myristoylation Regulates the Notch Ligand Jagged1
J. Biol. Chem.,
February 15, 2008;
283(7):
3846 - 3853.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Tao, H.-y. Wang, and C. C. Malbon
Src Docks to A-kinase Anchoring Protein Gravin, Regulating beta2-Adrenergic Receptor Resensitization and Recycling
J. Biol. Chem.,
March 2, 2007;
282(9):
6597 - 6608.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Ide, N. Nagasaki, R. Tomioka, M. Suito, T. Kamiya, and M. Maeshima
Molecular properties of a novel, hydrophilic cation-binding protein associated with the plasma membrane
J. Exp. Bot.,
March 1, 2007;
58(5):
1173 - 1183.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. M. E. Andriotis and J. P. Rathjen
The Pto Kinase of Tomato, Which Regulates Plant Immunity, Is Repressed by Its Myristoylated N Terminus
J. Biol. Chem.,
September 8, 2006;
281(36):
26578 - 26586.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Tao, E. Shumay, S. McLaughlin, H.-y. Wang, and C. C. Malbon
Regulation of AKAP-Membrane Interactions by Calcium
J. Biol. Chem.,
August 18, 2006;
281(33):
23932 - 23944.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Sanchez, B. Galy, T. Dandekar, P. Bengert, Y. Vainshtein, J. Stolte, M. U. Muckenthaler, and M. W. Hentze
Iron Regulation and the Cell Cycle: IDENTIFICATION OF AN IRON-RESPONSIVE ELEMENT IN THE 3'-UNTRANSLATED REGION OF HUMAN CELL DIVISION CYCLE 14A mRNA BY A REFINED MICROARRAY-BASED SCREENING STRATEGY
J. Biol. Chem.,
August 11, 2006;
281(32):
22865 - 22874.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Solito, H. C. Christian, M. Festa, A. Mulla, T. Tierney, R. J. Flower, and J. C. Buckingham
Post-translational modification plays an essential role in the translocation of annexin A1 from the cytoplasm to the cell surface
FASEB J,
July 1, 2006;
20(9):
1498 - 1500.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Sakurai and T. Utsumi
Posttranslational N-Myristoylation Is Required for the Anti-apoptotic Activity of Human tGelsolin, the C-terminal Caspase Cleavage Product of Human Gelsolin
J. Biol. Chem.,
May 19, 2006;
281(20):
14288 - 14295.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. L. Vilas, M. M. Corvi, G. J. Plummer, A. M. Seime, G. R. Lambkin, and L. G. Berthiaume
Posttranslational myristoylation of caspase-activated p21-activated protein kinase 2 (PAK2) potentiates late apoptotic events
PNAS,
April 25, 2006;
103(17):
6542 - 6547.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-i. Choi, H.-J. Park, J. H. Park, S. Kim, M.-Y. Im, H.-H. Seo, Y.-W. Kim, I. Hwang, and S. Y. Kim
Arabidopsis Calcium-Dependent Protein Kinase AtCPK32 Interacts with ABF4, a Transcriptional Regulator of Abscisic Acid-Responsive Gene Expression, and Modulates Its Activity
Plant Physiology,
December 1, 2005;
139(4):
1750 - 1761.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. E. Tucker, A. Stewart, L. Nallan, P. Bendale, F. Ghomashchi, M. H. Gelb, and C. C. Leslie
Group IVC cytosolic phospholipase A2{gamma} is farnesylated and palmitoylated in mammalian cells
J. Lipid Res.,
October 1, 2005;
46(10):
2122 - 2133.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Harashima and J. Heitman
G{alpha} Subunit Gpa2 Recruits Kelch Repeat Subunits That Inhibit Receptor-G Protein Coupling during cAMP-induced Dimorphic Transitions in Saccharomyces cerevisiae
Mol. Biol. Cell,
October 1, 2005;
16(10):
4557 - 4571.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Eichler and M. W. W. Adams
Posttranslational Protein Modification in Archaea
Microbiol. Mol. Biol. Rev.,
September 1, 2005;
69(3):
393 - 425.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. E. Ducker, J. J. Upson, K. J. French, and C. D. Smith
Two N-Myristoyltransferase Isozymes Play Unique Roles in Protein Myristoylation, Proliferation, and Apoptosis
Mol. Cancer Res.,
August 1, 2005;
3(8):
463 - 476.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Muralidhar, M. K. Jobby, K. Krishnan, V. Annapurna, K. V. R. Chary, A. Jeromin, and Y. Sharma
Equilibrium Unfolding of Neuronal Calcium Sensor-1: N-TERMINAL MYRISTOYLATION INFLUENCES UNFOLDING AND REDUCES PROTEIN STIFFENING IN THE PRESENCE OF CALCIUM
J. Biol. Chem.,
April 22, 2005;
280(16):
15569 - 15578.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Harkins, C. T. Cornell, and J. L. Whitton
Analysis of Translational Initiation in Coxsackievirus B3 Suggests an Alternative Explanation for the High Frequency of R+4 in the Eukaryotic Consensus Motif
J. Virol.,
January 15, 2005;
79(2):
987 - 996.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Perez, D. L. Greenwald, and J. C. de La Torre
Myristoylation of the RING Finger Z Protein Is Essential for Arenavirus Budding
J. Virol.,
October 15, 2004;
78(20):
11443 - 11448.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Muryoi, M. Sato, S. Kaneko, H. Kawahara, H. Obata, M. W. F. Yaish, M. Griffith, and B. R. Glick
Cloning and Expression of afpA, a Gene Encoding an Antifreeze Protein from the Arctic Plant Growth-Promoting Rhizobacterium Pseudomonas putida GR12-2
J. Bacteriol.,
September 1, 2004;
186(17):
5661 - 5671.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Ron
Signaling Cascades Regulating NMDA Receptor Sensitivity to Ethanol
Neuroscientist,
August 1, 2004;
10(4):
325 - 336.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Li, J. L. Franklin, R. Graves-Deal, W. G. Jerome, Z. Cao, and R. J. Coffey
Myristoylated Naked2 escorts transforming growth factor {alpha} to the basolateral plasma membrane of polarized epithelial cells
PNAS,
April 13, 2004;
101(15):
5571 - 5576.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Hedbacker, R. Townley, and M. Carlson
Cyclic AMP-Dependent Protein Kinase Regulates the Subcellular Localization of Snf1-Sip1 Protein Kinase
Mol. Cell. Biol.,
March 1, 2004;
24(5):
1836 - 1843.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. W. O'Callaghan, B. Hasdemir, M. Leighton, and R. D. Burgoyne
Residues within the myristoylation motif determine intracellular targeting of the neuronal Ca2+ sensor protein KChIP1 to post-ER transport vesicles and traffic of Kv4 K+ channels
J. Cell Sci.,
December 1, 2003;
116(23):
4833 - 4845.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Boisson, C. Giglione, and T. Meinnel
Unexpected Protein Families Including Cell Defense Components Feature in the N-Myristoylome of a Higher Eukaryote
J. Biol. Chem.,
October 31, 2003;
278(44):
43418 - 43429.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. S. Lin, J. K. Manchester, and J. I. Gordon
Sip2, an N-Myristoylated beta Subunit of Snf1 Kinase, Regulates Aging in Saccharomyces cerevisiae by Affecting Cellular Histone Kinase Activity, Recombination at rDNA Loci, and Silencing
J. Biol. Chem.,
April 4, 2003;
278(15):
13390 - 13397.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. P. Price, M. R. Menon, C. Panethymitaki, D. Goulding, P. G. McKean, and D. F. Smith
Myristoyl-CoA:Protein N-Myristoyltransferase, an Essential Enzyme and Potential Drug Target in Kinetoplastid Parasites
J. Biol. Chem.,
February 21, 2003;
278(9):
7206 - 7214.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Yamauchi, Y. Ejiri, and K. Tanaka
Glycation by Ascorbic Acid Causes Loss of Activity of Ribulose-1,5-Bisphosphate Carboxylase/Oxygenase and Its Increased Susceptibility to Proteases
Plant Cell Physiol.,
November 15, 2002;
43(11):
1334 - 1341.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|